Clinical and histologic characterization of dermatologic adverse events front the pan-PI3K inhibitor buparlisib (BKM-120) Meeting Abstract

  

Authors:	Schindler, K.; Abraham, R.; Shah, P. D.; Chandarlapaty, S.; Paik, P. K.; Bell-Mcguinn, K.; Bajorin, D. F.; Mellinghoff, I. K.; Younes, A.; Gounder, M. M.; Fury, M. G.; Busam, K. J.; Dickler, M. N.; Lacouture, M. E.
Abstract Title:	Clinical and histologic characterization of dermatologic adverse events front the pan-PI3K inhibitor buparlisib (BKM-120)
Meeting Title:	50th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	32
Issue:	15 Suppl.
Meeting Dates:	2014 May 30-Jun 3
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2014-05-20
Language:	English
ACCESSION:	WOS:000358613201615
PROVIDER:	wos
DOI:	10.1200/jco.2014.32.15_suppl.e20639
Notes:	Meeting Abstract: e20639 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/81047